User:KimmoPorkka
Kimmo Porkka M.D, Ph.D. is a professor of clinical hematology at the University of Helsinki and his current clinical position is Head of the Department of Hematology at the Helsinki University Hospital Comprehensive Cancer Center in Finland.
Dr. Porkka received his medical degrees at the Universities of Turku and Helsinki in Finland. He is board certified in internal medicine and hematology.
Dr. Porkka`s research experience includes clinical epidemiology, clinical breast cancer research, human molecular genetics (genetic mapping of complex diseases), basic and applied cancer research on characterization of leukemia-specific proteins and ligands (post-doctoral visit at the Burnham Institute, La Jolla, USA).
Dr. Porkka`s research relate to molecularly targeted therapies and immunotherapy of hematological malignancies. He has been the principal investigator in several Phase I-III clinical drug studies (academic and company-sponsored) on chronic myeloid leukemia and acute lymphoblastic and myeloid leukemia and performed closely linked translational science projects on leukemic stem cell targeting and immunomodulatory effects of tyrosine kinase inhibitors. Current research of Dr. Porkka focuses on individualized therapy of relapsed acute leukemia by high-throughput predictive drug testing ex vivo and molecular profiling aiming in rapid introduction of novel therapies (e.g. by drug repurposing). He is particularly interested in applying mathematical modeling for integration of big disease profiling data sources for clinical translation.
Dr. Porkka is the principal investigator in the Finnish Hematology Registry and Biobank (FHRB; fhrb.fi), which is a national, population-based registry and biobanking effort commencing in 2011. He is the past chairman of the Finnish Hematology Association.
Dr. Porkka is an active member of the European Hematology Association (EHA), currently serving in the EHA Executive Board and as the chair of the scientific program committee for the EHA annual meeting in 2020.
Prof. Porkka has more than 140 original publications in international peer reviewed journals, such as New England Journal of Medicine, Nature, Nature Medicine, Nature Genetics, PNAS, Journal of Clinical Oncology, Blood, and Leukemia